Clinical Trials Browser

Phase 4 × Completed × Ovarian Neoplasms × Clear all

Breast Neoplasms, Folic Acid Deficiency, Ovarian Neoplasms

NCT01932125 2025-06-26

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Phase 4 Completed

100 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT04330040 2025-03-10

SOLI

Phase 4 Completed

202 enrolled 15 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT03752216 2024-12-13

NiQoLe

Phase 4 Completed

141 enrolled

Gynecologic

Ovarian Neoplasms

NCT04352439 2022-09-26

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Phase 4 Completed

19 enrolled 10 charts

Classical hematologyGynecologic

Ovarian Neoplasms, Venous Thromboembolism

NCT00740116 2022-03-15

Tranexamic Acid in Surgery of Advanced Ovarian Cancer

Phase 4 Completed

100 enrolled 11 charts

Gynecologic

Ovarian Neoplasms, Thromboembolism, Blood Loss, Surgical, Postoperative Hemorrhage

NCT01953107 2021-05-12

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Phase 4 Completed

200 enrolled

Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT03543462 2020-05-22

DRAGON

Phase 4 Completed

88 enrolled

GynecologicThoracic

Ovarian Neoplasms, Pleural Effusion

NCT03384511 2018-02-20

The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

Phase 4 Completed

38 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT00727961 2017-06-08

A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)

Phase 4 Completed

58 enrolled 10 charts

Gynecologic

Ovarian Neoplasms

NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Phase 4 Completed

20 enrolled 5 charts

Gynecologic

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

NCT00817479 2016-07-13

Tumor Gene Expression in Women With Ovarian Cancer

Phase 4 Completed

20 enrolled 5 charts

Gynecologic

Ovarian Neoplasms

NCT00277160 2010-10-08

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Phase 4 Completed

852 enrolled

BreastGynecologicLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neutropenia, Ovarian Neoplasms

NCT00190697 2007-05-25

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Phase 4 Completed

70 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Clinical Trials

A Study of Serum Folate Levels in Patients Treated With Olaparib

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

SOLI

NiQoLe

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Tranexamic Acid in Surgery of Advanced Ovarian Cancer

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

DRAGON

The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Tumor Gene Expression in Women With Ovarian Cancer

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment